Despite long-standing promise and many known examples, antimicrobial peptides (AMPs) have failed, with few exceptions, to significantly impact human medicine. Impediments to the systemic activity of AMPs include proteolysis, host cell interactions, and serum protein binding, factors that are not often considered in the early stages of AMP development. Here we discuss how synthetic molecular evolution, iterative cycles of library design, and physiologically relevant screening can be used to evolve AMPs that do not have these impediments.
CITATION STYLE
Wimley, W. C. (2019). Application of synthetic molecular evolution to the discovery of antimicrobial peptides. In Advances in Experimental Medicine and Biology (Vol. 1117, pp. 241–255). Springer New York LLC. https://doi.org/10.1007/978-981-13-3588-4_13
Mendeley helps you to discover research relevant for your work.